Incidentaloma suprarrenal

Fassnacht, 2016, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors, Eur J Endocrinol, 175, G1, 10.1530/EJE-16-0467 Tabarin, 2008, Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus, Ann Endocrinol, 69, 487, 10.1016/j.ando.2008.09.003 Grumbach, 2003, Management of the clinically inapparent adrenal mass (“incidentaloma”), Ann Intern Med, 138, 424, 10.7326/0003-4819-138-5-200303040-00013 Young, 2007, Clinical practice. The incidentally discovered adrenal mass, N Engl J Med, 356, 601, 10.1056/NEJMcp065470 Mansmann, 2004, The clinically inapparent adrenal mass: update in diagnosis and management, Endocr Rev, 25, 309, 10.1210/er.2002-0031 Barzon, 2003, Prevalence and natural history of adrenal incidentalomas, Eur J Endocrinol, 149, 273, 10.1530/eje.0.1490273 Mantero, 2000, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology, J Clin Endocrinol Metab, 85, 637 Bovio, 2006, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series, J Endocrinol Invest, 29, 298, 10.1007/BF03344099 Caoili, 2002, Adrenal masses: characterization with combined unenhanced and delayed enhanced CT, Radiology, 222, 629, 10.1148/radiol.2223010766 Sangwaiya, 2010, Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort, Radiology, 256, 504, 10.1148/radiol.10091386 Korobkin, 1996, Adrenal adenomas: relationship between histologic lipid and CT and MR findings, Radiology, 200, 743, 10.1148/radiology.200.3.8756925 Haider, 2004, Chemical shift MR imaging of hyperattenuating (> 10 HU) adrenal masses: does it still have a role?, Radiology, 231, 711, 10.1148/radiol.2313030676 Lenders, 2014, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 99, 1915, 10.1210/jc.2014-1498 Launay, 2015, Value of 18-F-FDG PET/CT and CT in the diagnosis of indeterminate adrenal masses, Int J Endocrinol, 2015, 213875, 10.1155/2015/213875 Guerin, 2017, Performance of 18F-FDG PET/CT in the characterization of adrenal masses in non-cancer patients: a prospective study, J Clin Endocrinol Metab, 102, 2465, 10.1210/jc.2017-00254